Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,750
Closed -$1.4M 7
2018
Q3
$1.4M Hold
6,750
0.84% 44
2018
Q2
$1.25M Buy
6,750
+15
+0.2% +$2.65K 0.76% 46
2018
Q1
$1.15M Buy
6,735
+166
+3% +$30.5K 0.76% 44
2017
Q4
$1.14M Buy
6,569
+402
+7% +$71.1K 0.75% 44
2017
Q3
$1.15M Sell
6,167
-192
-3% -$34K 0.8% 40
2017
Q2
$1.09M Sell
6,359
-911
-13% -$148K 0.79% 44
2017
Q1
$1.19M Buy
7,270
+5
+0.1% +$831 0.9% 34
2016
Q4
$1.06M Buy
7,265
+28
+0.4% +$4.21K 0.86% 36
2016
Q3
$1.21M Buy
7,237
+86
+1% +$14.5K 1.02% 31
2016
Q2
$1.09M Buy
7,151
+229
+3% +$35.6K 0.93% 39
2016
Q1
$1.04M Buy
6,922
+1,370
+25% +$204K 0.9% 37
2015
Q4
$901K Buy
5,552
+356
+7% +$56K 0.81% 47
2015
Q3
$719K Buy
5,196
+391
+8% +$61.6K 0.75% 55
2015
Q2
$738K Buy
4,805
+2,524
+111% +$404K 0.69% 63
2015
Q1
$365K Buy
+2,281
New +$359K 0.37% 101

Other funds holding AMGN

Cue Advisory Services's AMGN Position: Q4 2018 in Review

Cue Advisory Services sold out of Amgen (AMGN) in Q4 2018, closing a stake of 6,750 shares — an estimated $1.4M sold.

Cue Advisory Services first reported a position in AMGN in Q1 2015 and held it in 15 quarters. The position peaked at $1.4M in Q3 2018. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Cue Advisory Services reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • Cue Advisory Services sold 6,750 Amgen shares in Q4 2018, an estimated $1.4M.
  • Cue Advisory Services first reported a position in Amgen in Q1 2015 and held it in 15 quarters.
  • Cue Advisory Services's Amgen position peaked at $1.4M in Q3 2018.
  • 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.